Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report sent to investors on Tuesday. The firm issued a sell rating on the stock.

Streamline Health Solutions Stock Up 1.6 %

Shares of NASDAQ STRM opened at $3.15 on Tuesday. Streamline Health Solutions has a 52 week low of $1.85 and a 52 week high of $9.75. The business has a 50-day simple moving average of $3.61 and a two-hundred day simple moving average of $3.42. The company has a quick ratio of 0.46, a current ratio of 0.46 and a debt-to-equity ratio of 0.72. The company has a market cap of $13.46 million, a P/E ratio of -1.31 and a beta of 1.77.

Streamline Health Solutions (NASDAQ:STRM) last issued its earnings results on Monday, December 16th. The company reported ($0.61) EPS for the quarter. Streamline Health Solutions had a negative return on equity of 56.96% and a negative net margin of 50.51%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.